Hostname: page-component-77c89778f8-fv566 Total loading time: 0 Render date: 2024-07-18T03:33:47.576Z Has data issue: false hasContentIssue false
  • English
  • Français

Pandemic science and commercial values: An institutional account of values in science

Published online by Cambridge University Press:  04 October 2023

Manuela Fernández Pinto Open the ORCID record for Manuela Fernández Pinto [Opens in a new window]
Manuela Fernández Pinto*
Affiliation:
Universidad de los Andes, Bogotá, Colombia African Centre for Epistemology and Philosophy of Science, University of Johannesburg, Johannesburg, South Africa
*
Email: m.fernandezp@uniandes.edu.co
Get access Rights & Permissions [Opens in a new window]

Abstract

The different social institutions involved in the development and distribution of science and technology tend to promote, primarily, commercial and private interests, even in situations with high social stakes. Acknowledging how these interests interplay with social and epistemic values is fundamental for understanding the role of values in science today. To show this, I use the global pandemic and the race to develop and distribute vaccines against COVID-19 as an example. I argue that a mere circumstantial alignment of values across the social institutions of science is not enough and that instead we need a more substantive alignment.

Type
Symposia Paper
Information
Philosophy of Science , First View , pp. 1 - 10
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the Philosophy of Science Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Emily, Barone. 2020. “The Trump Administration’s ‘Operation Warp Speed’ Has Spent $12.4 Billion on Vaccines. How Much Is That, Really?” TIME. Dec 14. https://time.com/5921360/operation-warp-speed-vaccine-spending/.Google Scholar
Berkley, Seth. 2020. “COVAX Explained.” GAVI. https://www.gavi.org/vaccineswork/covax-explained.Google Scholar
Blondel, Jean. 2006. “About Institutions, Mainly, but Not Exclusively, Political.” In The Oxford Handbook of Political Institutions, edited by Sarah Binder, R. A. W. Rhodes, and Rockman, Bert, 716–30. Oxford: Oxford University Press. https://doi.org/10.1093/oxfordhb/9780199548460.003.0036 Google Scholar
Chimpango, Boniface. 2021. “Vaccine Nationalism and Equitable Access to COVID-19 Pharmaceuticals: TRIPS Agreement under Trial (Again).” Journal of International Trade Law and Policy 20 (3):166–83. https://doi.org/10.1108/JITLP-03-2021-0012 CrossRefGoogle Scholar
Douglas, Heather. 2009. Science, Policy, and the Value-Free Ideal. Pittsburgh, PA: University of Pittsburgh Press. https://doi.org/10.2307/j.ctt6wrc78 CrossRefGoogle Scholar
European Commission. 2021. “EU Doubles Contribution to COVAX to €1 Billion to Ensure Safe and Effective Vaccines for Low and Middle-Income Countries.” Feb 19. https://ec.europa.eu/commission/presscorner/detail/en/IP_21_690.Google Scholar
Evenett, Simon. 2021. “Export Controls on COVID-19 Vaccines: Has the EU Opened Pandora’s Box?” Journal of World Trade 55 (3):397–408. https://doi.org/10.54648/trad2021016 CrossRefGoogle Scholar
Fernández Pinto, Manuela. 2022. “The Social Organization of Science during the COVID-19 Pandemic.” International Journal of Risk & Safety in Medicine 33 (3):223–28. https://doi.org/10.3233/jrs-227017 CrossRefGoogle ScholarPubMed
Fernández Pinto, Manuela. 2020. “Science and Industry Funding.” In Global Epistemologies and Philosophies of Science, edited by Ludwig, David, Koskinen, Inkeri, Mncube, Zinhle, Poliseli, Luana. and Reyes Galindo, L., 164–73. New York: Routledge. https://doi.org/10.4324/9781003027140-18 Google Scholar
Fernández Pinto, Manuela. 2018. “Democratizing Strategies for Industry-Funded Medical Research: A Cautionary Tale.” Philosophy of Science 85 (5):882–94. https://doi.org/10.1086/699720 CrossRefGoogle Scholar
Goldman, Alvin. 2011. “A Guide to Social Epistemology.” In Social Epistemology: Essential Readings, edited by Goldman, Alvin and Whitcomb, Dennis, 11–37. Oxford: Oxford University Press.Google Scholar
Heclo, Hugh. 2008. On Thinking Institutionally (on Politics). Oxford: Oxford University Press. https://doi.org/10.1093/oxfordhb/9780199548460.003.0037 Google Scholar
Hooker, Lucie, and Palumbo, Danielle. 2020. “Covid Vaccines: Will Drug Companies Make Bumper Profits?” BBC, Dec. 18. https://www.bbc.com/news/business-55170756.Google Scholar
Jupille, Joseph, and Caporaso, James A.. 2022. Theories of Institutions. Cambridge: Cambridge University Press. https://doi.org/10.1017/9781139034142 CrossRefGoogle Scholar
Kourany, Janet. 2010. Philosophy of Science after Feminism. New York: Oxford University Press. https://doi.org/10.1093/acprof:oso/9780199732623.001.0001 CrossRefGoogle Scholar
Le, T. Thanh, Andreadakis, Zacharias, Arun Kumar, R. Gómez Román, Tollefsen, Stig, Saville, Melanie, and Mayhew, Stephen. 2020a. “The COVID-19 Vaccine Development Landscape.” Nature Reviews Drug Discovery 19 (5):305–6. https://doi.org/10.1038/d41573-020-00073-5 CrossRefGoogle ScholarPubMed
Le, T. Thanh, Cramer, Jakob P., Jakob, P., Chen, Robert, and Mayhew, Stephen. 2020b. “Evolution of the COVID-19 Vaccine Development Landscape.” Nature Reviews Drug Discovery 19 (10):667–68. https://doi.org/10.1038/d41573-020-00151-8 CrossRefGoogle ScholarPubMed
Longino, Helen. 1990. Science as Social Knowledge: Values and Objectivity in Scientific Inquiry. Princeton, NJ: Princeton University Press. https://doi.org/10.1515/9780691209753 CrossRefGoogle Scholar
McHanon, Aisling. 2021. “Global Equitable Access to Vaccines, Medicines, and Diagnostics for COVID-19: The Role of Patents as Private Governance.” Journal of Medical Ethics 47:142–48. https://doi.org/10.1136/medethics-2020-106795 Google Scholar
Miller, Seumas. 2019. “Social Institutions.” In The Stanford Encyclopedia of Philosophy, edited by Edward N. Zalta. https://plato.stanford.edu/archives/sum2019/entries/social-institutions/.Google Scholar
Mitchell, Andrew, and Tania, Voon. 2009. “Patents and Public Health in the WTO, FTAs, and Beyond: Tension and Conflict in International Law.” Journal of World Trade 43 (3):571–601. https://doi.org/10.54648/trad2009023 Google Scholar
Oguanobi, Hembadoon I. 2018. “Broadening the Conversation on the TRIPS Agreement: Access to Medicines Includes Addressing Access to Medical Devices.” The Journal of World Intellectual Property 21:70–87. https://doi.org/10.1111/jwip.12091 CrossRefGoogle Scholar
Paton, James, and Lauerman, John. 2021. “When Lifesaving Vaccines Become Profit Machines for Drugmakers.” Bloomberg, July 5. https://www.bloomberg.com/news/articles/2021-07-06/when-lifesaving-vaccines-become-profit-machines-for-drugmakers#xj4y7vzkg.Google Scholar
Reisch, George A. 2005. How the Cold War Transformed Philosophy of Science: To the Icy Slopes of Logic. Cambridge: Cambridge University Press. https://doi.org/10.1017/cbo9780511610318 CrossRefGoogle Scholar
Rouse, Joseph. 1987. Knowledge and Power: Toward a Political Philosophy of Science. Ithaca, NY: Cornell University Press.Google Scholar
Scott, Richard. 2001. Institutions and Organisations. London: Sage.Google Scholar
So, Anthony D., and Woo, Joshua. 2020. “Reserving Coronavirus Disease 2019 Vaccines for Global Access: Cross Sectional Analysis.” British Medical Journal 371:m4750. https://doi.org/10.1136/bmj.m4750 CrossRefGoogle ScholarPubMed
Solomon, Miriam. 2001. Social Empiricism. Cambridge, MA: MIT Press. https://doi.org/10.7551/mitpress/6296.001.0001 CrossRefGoogle Scholar
The Economist. 2021. “Shots Fired: The Many Guises of Vaccines Nationalism.” Mar. 11. https://www.economist.com/finance-and-economics/2021/03/11/the-many-guises-of-vaccine-nationalism.Google Scholar
Turner, Jonathan. 1997. The Institutional Order. New York: Longman.Google Scholar
Usher, Ann D. 2020. “South Africa and India Push for COVID-19 Patents Ban.” The Lancet 396:1790–91. https://doi.org/10.1016/s0140-6736(20)32581-2 CrossRefGoogle ScholarPubMed
World Trade Organization. 1994. “TRIPS: Agreement on Trade-Related Aspects of Intellectual Property Rights.” April 15, Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, 1869 U.N.T.S. 299, 33 I.L.M. 1197. https://www.wto.org/english/docs_e/legal_e/27-trips.pdf.Google Scholar
Wouters, Olivier J., Shadlen, Kenneth C., Salcher-Konrad, Maximilian, Pollard, Andrew J., Larson, Heidi J., Teerawattananon, Yot, and Jit, Mark. 2021. “Challenges in Ensuring Global Access to COVID-19 Vaccines: Production, Affordability, Allocation, and Deployment.” The Lancet 397:1023–34. https://doi.org/10.1016/s0140-6736(21)00306-8 CrossRefGoogle ScholarPubMed